| Catholic University Industry Academic Cooperation Foundation Patent applications |
| Patent application number | Title | Published |
|---|
| 20120087900 | IMMUNOTHERAPEUTIC AGENT - The present invention is directed to adoptive immunotherapy using a lymphocyte in which an antigen-specific receptor and a bioactive material gene such as an IL-2 gene or a water-soluble TGF-beta receptor gene are transferred. The bioactive material is intensively secreted to, for example, a local site of a tumor, thereby reducing systemic side effects as much as possible, and the survival time of the lymphocyte is increased, thereby further improving the effect of the adoptive immunotherapy. | 04-12-2012 |
| 20120078297 | BIODEGRADABLE SUTURE TYPE CELL DELIVERY SYSTEM FOR IMPROVING STEM CELL ENGRAFTMENT RATE - The present invention relates to a biodegradable suture-type cell delivery system, a preparation method thereof and a biodegradable suture comprising the same. The biodegradable suture-type cell delivery system has improved cell compatibility as a result of depositing a hydrophilic functional group-containing compound on the surface of a biodegradable suture yarn made of a biodegradable polymer, a portion of which has partially a bulky structure beneficial for the proliferation of cells or living tissue, so as to hydrophilically modify the surface, and then bonding a cell compatible material to the surface, and also functions as a cell culture scaffold, because the bulky structure is beneficial for the proliferation of cells. Accordingly, the biodegradable suture-type cell delivery system can improve the rate of engraftment of stem cells in vivo. | 03-29-2012 |
| 20120058054 | GADOLINIUM COMPLEX, METHOD FOR PREPARING SAME, AND MRI CONTRAST AGENT COMPRISING SAME - Disclosed are a gadolinium complex formed by coordination of gadolinium to the diethylenetriaminepentaacetic acid dianhydride (DTPA) moiety of a pullulan-DTPA conjugate formed by an ester bond between pullulan and DTPA, a preparation method thereof, an MRI contrast composition comprising the complex, and a method of providing information for diagnosis of disease using the complex as an MRI contrast agent. The pullulan-DTPA-Gd complex has a long in vivo half-life, low toxicity, and high MRI signal intensity resulting in clear MRI images, compared to prior gadolinium complexes, indicating that it is advantageously used as an MRI contrast agent. In addition, it is possible to obtain MRI images allowing one to differentiate between diseased liver tissue and normal liver tissue, indicating that it is used as an MRI contrast agent for the liver. | 03-08-2012 |
| 20110287442 | Tumor Antigen Protein, Gene, or Peptides from Topoisimerase 2 Alpha - Provided is a tumor antigen protein, gene, or peptides derived from topoisomerase 2 alpha. As it is discovered that topoisomerase 2 alpha binds to an MHC class I or II antigen, thereby forming a complex, and the complex is recognized by cytotoxic T lymphocytes, the tumor antigen can be used in tumor immunotherapy. | 11-24-2011 |
| 20110246562 | VISUAL COMMUNICATION METHOD IN A MICROBLOG - A visual communication method adapted to microblogs is provided. The visual communication method comprises analyzing, by a server, a user's input text using context and words, extracting, by the server, a picture corresponding to the text using a multimedia classification system data base, creating, by the server, an avatar representing the user, synthesizing, by the server, the picture and the avatar into one multimedia form, and transferring, by the server, the synthesized multimedia to the user's microblog. | 10-06-2011 |
| 20110242128 | USER'S PREFERENCE APPLIED FEELING-BASED IMAGE COLOR CONTROL METHOD USING INTERACTIVE GENETIC ALGORITHM - A method is provided that controls the color of a feeling-based image reflecting a user's preference via an interactive genetic algorithm. The method is performed in such a manner that a range of candidate colors is defined by type of feelings as templates, one from among the candidate templates, as the final template, is selected by learning a user's color preference via an interactive genetic algorithm, and then the color of an image is controlled based on the final template by recognizing a user's feeling. | 10-06-2011 |
| 20110213142 | Method for Producing Biological Heme Iron, and Iron Supplementing Composition Containing the Heme Iron Produced By Same - The present invention relates to a method for biologically producing heme-iron through microorganism cultivation, and to an iron supplementing composition containing the heme-iron produced by the same. The present invention provides a method for biologically producing heme-iron through microorganism cultivation, making it possible to economically produce heme-iron or heme-iron preparations which can be safely used as an iron supplement. | 09-01-2011 |
| 20090155830 | Composition and a kit for detecting early apoptosis in frozen umbilical cord and a method therefor - There are provided a composition and kit for detecting early apoptosis in cryopreserved umbilical cord blood stem cells, and a method therefor. According to the present invention, when the umbilical cord blood stem cells are cryopreserved and later used for cell therapy, the quality of umbilical cord blood is assessed and early apoptosis in the umbilical cord blood stem cells is detected. The obtained resulting data, which can be used as a quality reference for umbilical cord blood required for transplantation, reflect the engraftment levels after in vivo transplantation of the stem cells, and thus allow prediction of the engraftment levels from the results. | 06-18-2009 |
